Real-World Data and Real-World Evidence in Lung Cancer Volume II

105
Total downloads
1,298
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Accepted on 13 May 2025

Cost-effectiveness analysis of first-line Tislelizumab plus chemotherapy for extensive-stage small cell lung cancer from the perspective of the healthcare system in China

Feng Chen
Xue Feng
Lin Lin Xiao
Juan Hai Tang
Shu Xia Qin
Jie Ping Peng
Jing Bai

doi 10.3389/fpubh.2025.1552734

100 views

ORIGINAL RESEARCH

Published on 01 May 2025

Real-world analysis of the efficacy and safety of lorlatinib in ALK-positive non-small cell lung cancer patients in China

Guangming Tian
Jun Nie
Ling Dai
Weiheng Hu
Jie Zhang
Di Wu
Xiangjuan Ma
Xiaoling Chen
Sen Han
4 more
Jian Fang

doi 10.3389/fonc.2025.1577607

674 views

Share on

Frontiers in Oncology

Frontiers in Oncology

Thoracic Oncology

Participating Journals

Frontiers in Public Health
- Health Economics
- 3.0 impact factor
- 4.8 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

1,298Topic views
774Article views
105Article downloads